# cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China

> **NCT02980536** · — · UNKNOWN · sponsor: **Berry Genomics Co., Ltd.** · enrollment: 129 (actual)

## Conditions studied

- Nonsmall Cell Lung Cancer
- Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02980536
- **Lead sponsor:** Berry Genomics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2018-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02980536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02980536, "cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02980536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*